ClinicalTrials.gov record
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
ClinicalTrials.gov ID: NCT00153062
Public ClinicalTrials.gov record NCT00153062. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis
Study identification
- NCT ID
- NCT00153062
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 20,332 participants
Conditions and interventions
Conditions
Interventions
- Aggrenox Drug
- Clopidogrel placebo Drug
- Micardis Drug
- Aggrenox placebo Drug
- Clopidogrel Drug
- Micardis placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2003
- Primary completion
- Mar 31, 2008
- Completion
- Not listed
- Last update posted
- May 12, 2014
Started 2003
United States locations
- U.S. sites
- 204
- U.S. states
- 43
- U.S. cities
- 163
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 9.159.1101 Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| 9.159.1173 Boehringer Ingelheim Investigational Site | Huntsville | Alabama | — | — |
| 9.159.1058 Boehringer Ingelheim Investigational Site | Mobile | Alabama | — | — |
| 9.159.1087 Boehringer Ingelheim Investigational Site | Montgomery | Alabama | — | — |
| 9.159.1081 Boehringer Ingelheim Investigational Site | Northport | Alabama | — | — |
| 9.159.1022 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 9.159.1133 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 9.159.1149 Boehringer Ingelheim Investigational Site | Phoenix | Arizona | — | — |
| 9.159.1137 Boehringer Ingelheim Investigational Site | Tucson | Arizona | — | — |
| 9.159.1184 Boehringer Ingelheim Investigational Site | Fayetteville | Arkansas | — | — |
| 9.159.1005 Boehringer Ingelheim Investigational Site | Fort Smith | Arkansas | — | — |
| 9.159.1136 Boehringer Ingelheim Investigational Site | Jonesboro | Arkansas | — | — |
| 9.159.1062 Boehringer Ingelheim Investigational Site | Little Rock | Arkansas | — | — |
| 9.159.1040 Boehringer Ingelheim Investigational Site | Berkeley | California | — | — |
| 9.159.1180 Boehringer Ingelheim Investigational Site | Carmichael | California | — | — |
| 9.159.1114 Boehringer Ingelheim Investigational Site | Irvine | California | — | — |
| 9.159.1202 Boehringer Ingelheim Investigational Site | Laguna Hills | California | — | — |
| 9.159.1036 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 9.159.1052 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 9.159.1100 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 9.159.1111 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 9.159.1165 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 9.159.1134 Boehringer Ingelheim Investigational Site | Oceanside | California | — | — |
| 9.159.1002 Boehringer Ingelheim Investigational Site | Palo Alto | California | — | — |
| 9.159.1108 Boehringer Ingelheim Investigational Site | Redding | California | — | — |
| 9.159.1013 Boehringer Ingelheim Investigational Site | Sacramento | California | — | — |
| 9.159.1198 Boehringer Ingelheim Investigational Site | Sacramento | California | — | — |
| 9.159.1029 Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| 9.159.1185 Boehringer Ingelheim Investigational Site | San Francisco | California | — | — |
| 9.159.1218 Boehringer Ingelheim Investigational Site | San Jose | California | — | — |
| 9.159.1179 Boehringer Ingelheim Investigational Site | Santa Rosa | California | — | — |
| 9.159.1162 Boehringer Ingelheim Investigational Site | Sylmar | California | — | — |
| 9.159.1183 Boehringer Ingelheim Investigational Site | Torrance | California | — | — |
| 9.159.1205 Boehringer Ingelheim Investigational Site | Walnut Creek | California | — | — |
| 9.159.1118 Boehringer Ingelheim Investigational Site | Denver | Colorado | — | — |
| 9.159.1045 Boehringer Ingelheim Investigational Site | Englewood | Colorado | — | — |
| 9.159.1038 Boehringer Ingelheim Investigational Site | Danbury | Connecticut | — | — |
| 9.159.1196 Boehringer Ingelheim Investigational Site | Fairfield | Connecticut | — | — |
| 9.159.1018 Boehringer Ingelheim Investigational Site | Hartford | Connecticut | — | — |
| 9.159.1080 Boehringer Ingelheim Investigational Site | Newark | Delaware | — | — |
| 9.159.1120 Boehringer Ingelheim Investigational Site | Washington D.C. | District of Columbia | — | — |
| 9.159.1216 Boehringer Ingelheim Investigational Site | Washington D.C. | District of Columbia | — | — |
| 9.159.1057 Boehringer Ingelheim Investigational Site | Bay Pines | Florida | — | — |
| 9.159.1217 Boehringer Ingelheim Investigational Site | Boca Raton | Florida | — | — |
| 9.159.1096 Boehringer Ingelheim Investigational Site | Bradenton | Florida | — | — |
| 9.159.1144 Boehringer Ingelheim Investigational Site | Clearwater | Florida | — | — |
| 9.159.1007 Boehringer Ingelheim Investigational Site | Fort Lauderdale | Florida | — | — |
| 9.159.1190 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | — | — |
| 9.159.1150 Boehringer Ingelheim Investigational Site | Ocala | Florida | — | — |
| 9.159.1153 Boehringer Ingelheim Investigational Site | Panama City | Florida | — | — |
| 9.159.1041 Boehringer Ingelheim Investigational Site | Plantation | Florida | — | — |
| 9.159.1072 Boehringer Ingelheim Investigational Site | Port Charlotte | Florida | — | — |
| 9.159.1063 Boehringer Ingelheim Investigational Site | Sarasota | Florida | — | — |
| 9.159.1208 Boehringer Ingelheim Investigational Site | Tampa | Florida | — | — |
| 9.159.1049 Boehringer Ingelheim Investigational Site | Vero Beach | Florida | — | — |
| 9.159.1176 Boehringer Ingelheim Investigational Site | West Palm Beach | Florida | — | — |
| 9.159.1071 Boehringer Ingelheim Investigational Site | Atlanta | Georgia | — | — |
| 9.159.1079 Boehringer Ingelheim Investigational Site | Augusta | Georgia | — | — |
| 9.159.1181 Boehringer Ingelheim Investigational Site | Columbus | Georgia | — | — |
| 9.159.1138 Boehringer Ingelheim Investigational Site | Decatur | Georgia | — | — |
| 9.159.1070 Boehringer Ingelheim Investigational Site | Rome | Georgia | — | — |
| 9.159.1107 Boehringer Ingelheim Investigational Site | Savannah | Georgia | — | — |
| 9.159.1189 Boehringer Ingelheim Investigational Site | Boise | Idaho | — | — |
| 9.159.1026 University of Illinois | Chicago | Illinois | — | — |
| 9.159.1033 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 9.159.1060 Boehringer Ingelheim Investigational Site | Chicago | Illinois | — | — |
| 9.159.1044 Boehringer Ingelheim Investigational Site | Maywood | Illinois | — | — |
| 9.159.1054 Boehringer Ingelheim Investigational Site | Palos Heights | Illinois | — | — |
| 9.159.1068 Boehringer Ingelheim Investigational Site | Park Ridge | Illinois | — | — |
| 9.159.1178 Boehringer Ingelheim Investigational Site | Peoria | Illinois | — | — |
| 9.159.1156 Boehringer Ingelheim Investigational Site | Elkhart | Indiana | — | — |
| 9.159.1092 Boehringer Ingelheim Investigational Site | South Bend | Indiana | — | — |
| 9.159.1027 Boehringer Ingelheim Investigational Site | Cedar Rapids | Iowa | — | — |
| 9.159.1119 Boehringer Ingelheim Investigational Site | Des Moines | Iowa | — | — |
| 9.159.1187 Boehringer Ingelheim Investigational Site | Des Moines | Iowa | — | — |
| 9.159.1059 Boehringer Ingelheim Investigational Site | Iowa City | Iowa | — | — |
| 9.159.1135 Boehringer Ingelheim Investigational Site | Waterloo | Iowa | — | — |
| 9.159.1090 Boehringer Ingelheim Investigational Site | Kansas City | Kansas | — | — |
| 9.159.1129 Central Baptis Hospital | Lexington | Kentucky | — | — |
| 9.159.1131 Boehringer Ingelheim Investigational Site | Lexington | Kentucky | — | — |
| 9.159.1206 Boehringer Ingelheim Investigational Site | Lexington | Kentucky | — | — |
| 9.159.1212 Boehringer Ingelheim Investigational Site | Lexington | Kentucky | — | — |
| 9.159.1091 Boehringer Ingelheim Investigational Site | Louisville | Kentucky | — | — |
| 9.159.1147 Boehringer Ingelheim Investigational Site | Louisville | Kentucky | — | — |
| 9.159.1106 Boehringer Ingelheim Investigational Site | Baton Rouge | Louisiana | — | — |
| 9.159.1194 Boehringer Ingelheim Investigational Site | Marrero | Louisiana | — | — |
| 9.159.1083 Boehringer Ingelheim Investigational Site | New Orleans | Louisiana | — | — |
| 9.159.1195 Boehringer Ingelheim Investigational Site | Shreveport | Louisiana | — | — |
| 9.159.1024 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 9.159.1055 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 9.159.1139 Boehringer Ingelheim Investigational Site | Baltimore | Maryland | — | — |
| 9.159.1031 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 9.159.1066 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 9.159.1104 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 9.159.1166 Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| 9.159.1192 Boehringer Ingelheim Investigational Site | South Weymouth | Massachusetts | — | — |
| 9.159.1039 Boehringer Ingelheim Investigational Site | Worchester | Massachusetts | — | — |
| 9.159.1019 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 9.159.1048 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 9.159.1089 Boehringer Ingelheim Investigational Site | Detroit | Michigan | — | — |
| 9.159.1078 Boehringer Ingelheim Investigational Site | East Lansing | Michigan | — | — |
| 9.159.1143 Boehringer Ingelheim Investigational Site | Grand Rapids | Michigan | — | — |
| 9.159.1102 Boehringer Ingelheim Investigational Site | Kalamazoo | Michigan | — | — |
| 9.159.1011 Boehringer Ingelheim Investigational Site | Saginaw | Michigan | — | — |
| 9.159.1132 Boehringer Ingelheim Investigational Site | Southfield | Michigan | — | — |
| 9.159.1088 Boehringer Ingelheim Investigational Site | Duluth | Minnesota | — | — |
| 9.159.1158 Boehringer Ingelheim Investigational Site | Duluth | Minnesota | — | — |
| 9.159.1084 Boehringer Ingelheim Investigational Site | Golden Valley | Minnesota | — | — |
| 9.159.1097 Boehringer Ingelheim Investigational Site | Minneapolis | Minnesota | — | — |
| 9.159.1113 Boehringer Ingelheim Investigational Site | Minneapolis | Minnesota | — | — |
| 9.159.1128 St. Luke's Hospital MABSI Research | Kansas City | Missouri | — | — |
| 9.159.1172 Boehringer Ingelheim Investigational Site | Lees Summit | Missouri | — | — |
| 9.159.1009 Boehringer Ingelheim Investigational Site | Springfield | Missouri | — | — |
| 9.159.1174 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 9.159.1182 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 9.159.1191 Boehringer Ingelheim Investigational Site | St Louis | Missouri | — | — |
| 9.159.1146 Boehringer Ingelheim Investigational Site | Great Falls | Montana | — | — |
| 9.159.1201 Boehringer Ingelheim Investigational Site | Omaha | Nebraska | — | — |
| 9.159.1127 Boehringer Ingelheim Investigational Site | Las Vegas | Nevada | — | — |
| 9.159.1188 Boehringer Ingelheim Investigational Site | Reno | Nevada | — | — |
| 9.159.1204 Boehringer Ingelheim Investigational Site | Camden | New Jersey | — | — |
| 9.159.1203 Boehringer Ingelheim Investigational Site | Edison | New Jersey | — | — |
| 9.159.1042 Neurology Consultants of Burlington County | Lumberton | New Jersey | — | — |
| 9.159.1209 Boehringer Ingelheim Investigational Site | New Brunswick | New Jersey | — | — |
| 9.159.1125 Boehringer Ingelheim Investigational Site | Newark | New Jersey | — | — |
| 9.159.1095 Boehringer Ingelheim Investigational Site | Ridgewood | New Jersey | — | — |
| 9.159.1170 Boehringer Ingelheim Investigational Site | Albuquerque | New Mexico | — | — |
| 9.159.1086 Boehringer Ingelheim Investigational Site | Albany | New York | — | — |
| 9.159.1017 Boehringer Ingelheim Investigational Site | Brooklyn | New York | — | — |
| 9.159.1064 Boehringer Ingelheim Investigational Site | Brooklyn | New York | — | — |
| 9.159.1186 Boehringer Ingelheim Investigational Site | Brooklyn | New York | — | — |
| 9.159.1151 Boehringer Ingelheim Investigational Site | Buffalo | New York | — | — |
| 9.159.1076 North Shore University Hospital | Manasset | New York | — | — |
| 9.159.1037 Boehringer Ingelheim Investigational Site | Mineola | New York | — | — |
| 9.159.1220 Boehringer Ingelheim Investigational Site | New Hyde Park | New York | — | — |
| 9.159.1001 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 9.159.1116 Boehringer Ingelheim Investigational Site | New York | New York | — | — |
| 9.159.1142 Saint Luke's-Roosevelt Hospital | New York | New York | — | — |
| 9.159.1126 Boehringer Ingelheim Investigational Site | Schenectady | New York | — | — |
| 9.159.1163 Boehringer Ingelheim Investigational Site | Stony Brook | New York | — | — |
| 9.159.1121 Boehringer Ingelheim Investigational Site | The Bronx | New York | — | — |
| 9.159.1130 Boehringer Ingelheim Investigational Site | The Bronx | New York | — | — |
| 9.159.1169 Boehringer Ingelheim Investigational Site | Tonawanda | New York | — | — |
| 9.159.1065 Boehringer Ingelheim Investigational Site | White Plains | New York | — | — |
| 9.159.1099 Boehringer Ingelheim Investigational Site | Asheville | North Carolina | — | — |
| 9.159.1046 Boehringer Ingelheim Investigational Site | Chapel Hill | North Carolina | — | — |
| 9.159.1094 Boehringer Ingelheim Investigational Site | Durham | North Carolina | — | — |
| 9.159.1012 Boehringer Ingelheim Investigational Site | High Point | North Carolina | — | — |
| 9.159.1115 | Wilmington | North Carolina | — | — |
| 9.159.1051 Boehringer Ingelheim Investigational Site | Winston-Salem | North Carolina | — | — |
| 9.159.1110 Boehringer Ingelheim Investigational Site | Winston-Salem | North Carolina | — | — |
| 9.159.1215 Boehringer Ingelheim Investigational Site | Bismarck | North Dakota | — | — |
| 9.159.1152 Boehringer Ingelheim Investigational Site | Fargo | North Dakota | — | — |
| 9.159.1159 Boehringer Ingelheim Investigational Site | Akron | Ohio | — | — |
| 9.159.1085 Boehringer Ingelheim Investigational Site | Canton | Ohio | — | — |
| 9.159.1032 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 9.159.1025 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 9.159.1177 Boehringer Ingelheim Investigational Site | Cleveland | Ohio | — | — |
| 9.159.1008 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 9.159.1141 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 9.159.1053 Boehringer Ingelheim Investigational Site | Toledo | Ohio | — | — |
| 9.159.1122 Boehringer Ingelheim Investigational Site | Youngstown | Ohio | — | — |
| 9.159.1199 Boehringer Ingelheim Investigational Site | Oklahoma City | Oklahoma | — | — |
| 9.159.1010 Boehringer Ingelheim Investigational Site | Portland | Oregon | — | — |
| 9.159.1171 Boehringer Ingelheim Investigational Site | Abington | Pennsylvania | — | — |
| 9.159.1210 Boehringer Ingelheim Investigational Site | Allentown | Pennsylvania | — | — |
| 9.159.1214 Boehringer Ingelheim Investigational Site | Allentown | Pennsylvania | — | — |
| 9.159.1200 Boehringer Ingelheim Investigational Site | Erie | Pennsylvania | — | — |
| 9.159.1043 Boehringer Ingelheim Investigational Site | Greensburg | Pennsylvania | — | — |
| 9.159.1164 Boehringer Ingelheim Investigational Site | Hershey | Pennsylvania | — | — |
| 9.159.1175 Boehringer Ingelheim Investigational Site | Lancaster | Pennsylvania | — | — |
| 9.159.1016 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 9.159.1056 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 9.159.1074 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 9.159.1112 Boehringer Ingelheim Investigational Site | Pittsburgh | Pennsylvania | — | — |
| 9.159.1148 Boehringer Ingelheim Investigational Site | Upland | Pennsylvania | — | — |
| 9.159.1123 Boehringer Ingelheim Investigational Site | Providence | Rhode Island | — | — |
| 9.159.1140 Boehringer Ingelheim Investigational Site | Columbia | South Carolina | — | — |
| 9.159.1207 Boehringer Ingelheim Investigational Site | Greenville | South Carolina | — | — |
| 9.159.1004 Boehringer Ingelheim Investigational Site | Spartanburg | South Carolina | — | — |
| 9.159.1006 Boehringer Ingelheim Investigational Site | Bristol | Tennessee | — | — |
| 9.159.1154 Boehringer Ingelheim Investigational Site | Knoxville | Tennessee | — | — |
| 9.159.1213 Boehringer Ingelheim Investigational Site | Memphis | Tennessee | — | — |
| 9.159.1075 Boehringer Ingelheim Investigational Site | Nashville | Tennessee | — | — |
| 9.159.1219 Boehringer Ingelheim Investigational Site | Brownwood | Texas | — | — |
| 9.159.1155 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 9.159.1197 Boehringer Ingelheim Investigational Site | Dallas | Texas | — | — |
| 9.159.1020 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 9.159.1023 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 9.159.1082 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 9.159.1160 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 9.159.1047 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 9.159.1069 Boehringer Ingelheim Investigational Site | Tyler | Texas | — | — |
| 9.159.1003 Boehringer Ingelheim Investigational Site | Bountiful | Utah | — | — |
| 9.159.1077 Boehringer Ingelheim Investigational Site | Newport News | Virginia | — | — |
| 9.159.1021 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 9.159.1061 Boehringer Ingelheim Investigational Site | Salem | Virginia | — | — |
| 9.159.1014 Boehringer Ingelheim Investigational Site | Seattle | Washington | — | — |
| 9.159.1145 Boehringer Ingelheim Investigational Site | Spokane | Washington | — | — |
| 9.159.1211 Boehringer Ingelheim Investigational Site | Charleston | West Virginia | — | — |
| 9.159.1035 Boehringer Ingelheim Investigational Site | Morgantown | West Virginia | — | — |
| 9.159.1030 Boehringer Ingelheim Investigational Site | Marshfield | Wisconsin | — | — |
| 9.159.1117 Boehringer Ingelheim Investigational Site | Milwaukee | Wisconsin | — | — |
| 9.159.1098 Community Healthcare Clinic Westhill Medical Specialists | Wausau | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 463 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00153062, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2014 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00153062 live on ClinicalTrials.gov.